Pages that link to "Q48199971"
Jump to navigation
Jump to search
The following pages link to Can estradiol modulate schizophrenic symptomatology? (Q48199971):
Displaying 50 items.
- A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings (Q26778420) (← links)
- Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males (Q30474007) (← links)
- Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women (Q30475518) (← links)
- The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples (Q33332023) (← links)
- Event-related brain potentials to emotional images and gonadal steroid hormone levels in patients with schizophrenia and paired controls (Q33737973) (← links)
- The role of estrogen in schizophrenia. (Q33921706) (← links)
- Clinical features of schizophrenia in a woman with hyperandrogenism. (Q33921854) (← links)
- Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia (Q33932787) (← links)
- Is oestrogen a 'biological neuroleptic'? (Q34187159) (← links)
- Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. (Q34191380) (← links)
- Why does schizophrenia develop at late adolescence? (Q34212774) (← links)
- Peripheral oxytocin is associated with reduced symptom severity in schizophrenia (Q34311629) (← links)
- Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. (Q34476635) (← links)
- The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women (Q34708414) (← links)
- Reduced hippocampal volume and hypothalamus-pituitary-adrenal axis function in first episode psychosis: evidence for sex differences (Q34988625) (← links)
- Analyzing the influence of BDNF heterozygosity on spatial memory response to 17β-estradiol (Q35034804) (← links)
- Experience effects on brain development: possible contributions to psychopathology (Q35054901) (← links)
- Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia (Q35089938) (← links)
- Detection and management of comorbidity in patients with schizophrenia (Q35102472) (← links)
- Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses (Q35629698) (← links)
- Perimenopausal mental disorders: epidemiology and phenomenology. (Q36134832) (← links)
- Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. (Q36168604) (← links)
- The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia (Q36168609) (← links)
- Schizophrenia: a unique translational opportunity in behavioral neuroendocrinology (Q36547921) (← links)
- Sex, hormones and affective arousal circuitry dysfunction in schizophrenia (Q36550403) (← links)
- Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia (Q36769292) (← links)
- Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery (Q36992707) (← links)
- Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder (Q37032774) (← links)
- Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial (Q37076464) (← links)
- Absence of established sex differences in patients with schizophrenia on a two-dimensional object array task (Q37243714) (← links)
- Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia. (Q37349868) (← links)
- The role of estrogen in the treatment of men with schizophrenia (Q37385678) (← links)
- Menstrual Cycle in Schizophrenic Patients: Review with a Case (Q37703947) (← links)
- Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders (Q37765941) (← links)
- Sex steroids and schizophrenia (Q37878384) (← links)
- Menstrual exacerbation of schizophrenia symptoms (Q37974921) (← links)
- Role of estrogen treatment in the management of schizophrenia (Q38012857) (← links)
- Acute and transient psychotic disorder in a developing country (Q38126477) (← links)
- A survey on issues in the lives of women with severe mental illness (Q38555900) (← links)
- Why estrogens matter for behavior and brain health (Q38796711) (← links)
- Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia (Q38876224) (← links)
- Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders (Q38993187) (← links)
- Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses (Q39011242) (← links)
- Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms (Q39412337) (← links)
- High estrogen and chronic haloperidol lead to greater amphetamine-induced BOLD activation in awake, amphetamine-sensitized female rats. (Q39787246) (← links)
- Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia (Q40728389) (← links)
- Schizophrenia and oestrogens--is there an association? (Q40821993) (← links)
- What do we really know about late-onset schizophrenia? (Q41614039) (← links)
- Psychopathology in Women and Men: Focus on Female Hormones (Q41660542) (← links)
- Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis (Q42266503) (← links)